DNA encoding orphan SNORF13c receptor

Abstract

This invention provides a recombinant nucleic acid comprising a nucleic acid encoding a mammalian SNORF13 receptor, wherein the mammalian receptor-encoding nucleic acid hybridizes under high stringency conditions to a nucleic acid encoding a human SNORF13 receptor and having a sequence identical to the sequence of either one of the human SNORF13a receptor-encoding nucleic acid contained in plasmid pEXJ.T3T7hSNORF13a-f (Patent Deposit Designation No. PTA-______), the human SNORF13b receptor-encoding nucleic acid contained in plasmid pEXJ.T3T7-hSNORF13b-f (Patent Deposit Designation No. PTA-______), the human SNORF13c receptor-encoding nucleic acid contained in plasmid pEXJ.T3T7-hSNORF13c-f (Patent Deposit Designation No. PTA-______), or the human SNORF13d receptor-encoding nucleic acid contained in plasmid pEXJ.T3T7-hSNORF13d-f (Patent Deposit Designation No. PTA-______) This invention further provides a recombinant nucleic acid comprising a nucleic acid encoding a human SNORF13 receptor, wherein the human SNORF13 receptor comprises (a) an amino acid sequence identical to the sequence of the human SNORF13c receptor encoded by the shortest open reading frame indicated in FIGS. 5A-5G (SEQ ID NO: 5) or (b) an amino acid sequence that varies from the sequence of (a) by either the exclusion of amino acids 19-86, the replacement of amino acids 195-200 with amino acid I (isoleucine), or the exclusion of amino acids 19-86 and the replacement of amino acids 195-200 with amino acid I (isoleucine).

Dependencies are inferred from the claim text.